In this issue
Does the storage duration of blood products affect outcomes in critically ill patients?
A patient-centric approach to preventing allergic reactions to platelet transfusions
Dengue: a potential transfusion-transmitted disease
An old-fashioned transfusion
How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations?
Lack of effect of unrefrigerated young whole blood transfusion on patient outcomes after massive transfusion in a civilian setting
Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction
The appropriateness of red blood cell use and the extent of overtransfusion: right decision? Right amount?
A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients
Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study
Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes
Modeling transfusion reactions and predicting in vivo cell survival with kodecytes
Continuing Medical Education Program in Transfusion
Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)
Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors
A new platelet alloantigen, Swia, located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia
Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow–derived cells with features of mesenchymal stem cells
Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation
A randomized clinical trial comparing granulocyte–colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation
The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels
Enhancing blood donation intentions using multimedia donor education materials
Effect of applied muscle tension on cerebral oxygenation in female blood donors
Barriers to blood donation in African communities in Australia: the role of home and host country culture and experience
Healthy donor effect: its magnitude in health research among blood donors
Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior
Effect on the quality of blood components after simulated blood transfusions using volumetric infusion pumps
Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors
Pitfalls in the current published observational literature on the effects of red blood cell storage
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety
Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom
Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom
ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants
Conditions for plasma processing
Conditions for plasma processing